How big is the IVD market | Growth, Size & Insights 2026

Q: What is the market size of the IVD market in 2025 and 2031?

The IVD market was expected to be valued at approximately USD 93.2 billion in 2025 and projected to reach around USD 142.7 billion by 2031.

Q: What is the CAGR of the IVD market between 2025 and 2031?

The IVD market is anticipated to grow at a CAGR of 6.3% during the forecast period.

Q: What are the key trends in the IVD market?

Key trends include the adoption of molecular and personalized diagnostics, increasing demand for point-of-care and home-based testing, and integration of digital tools in IVD platforms.

Q: What are the main drivers of the IVD market?

The IVD market is driven by a rising burden of chronic diseases, increasing focus on early and accurate diagnosis, growth in technological innovation, and expanding healthcare.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA7206

Publication Date: Jul 2025

What is the IVD Market Size?

According to 6Wresearch internal database and industry insights, the IVD (In-Vitro Diagnostics) market was valued at USD 93.2 billion in 2025 and is projected to exceed USD 142.7 billion by 2032, expanding at a CAGR of 6.3% during the forecast period.

This market is witnessing consistent growth owing to the rising prevalence of chronic and infectious diseases, increasing awareness about early disease detection, and growing adoption of personalized medicine. Further, advancements in diagnostic technologies, expansion of point-of-care testing, and integration of AI and digital tools are supporting the rapid evolution of the IVD industry.

Major Growth Factors of the IVD Market

Rising prevalence of chronic and infectious diseases
Increasing demand for point-of-care testing
Growing use of molecular diagnostics
Technological advancements in diagnostic platforms
Increasing geriatric population and related health issues
Integration of AI and digital health in diagnostics
Expansion of healthcare infrastructure in emerging markets
Government initiatives for early disease detection

IVD Market Trends

The IVD market is anticipated to experience strong momentum driven by increased use of molecular and genetic testing, especially in oncology and infectious disease diagnostics. There’s a growing shift toward personalized healthcare and real-time diagnostics, facilitated by AI integration and digital platforms. Point-of-care testing and home diagnostics are becoming increasingly mainstream, particularly in developed regions.

Emerging Developments in the IVD Market

The IVD market is estimated to witness significant R&D investment toward rapid and portable testing solutions. Companies are focusing on next-generation sequencing (NGS) and liquid biopsy technologies. Additionally, strategic partnerships between diagnostic companies and healthcare providers are enabling faster deployment of innovative diagnostic solutions worldwide.